Karaduman, Bilge DuranKaraduman, Bilge DuranAyhan, HüseyinAyhan, HuseyinKeles, TelatBozkurt, Engin2024-07-052024-07-05202130003-49751552-625910.1016/j.athoracsur.2021.03.0142-s2.0-85119264732https://doi.org/10.1016/j.athoracsur.2021.03.014https://hdl.handle.net/20.500.14411/1723AYHAN, Hüseyin/0000-0002-9991-7307The transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system. (C) 2021 by The Society of Thoracic Surgeonseninfo:eu-repo/semantics/closedAccess[No Keyword Available]EditorialQ11126E435E437WOS:00072256040001333737045